https://doi.org/10.36719/2707-1146/54/35-45
Asli Javadzadeh
Baku State University
https://orcid.org/0009-0008-7882-9894
aslicavadzada1@mail.ru
Goncha Aghazadeh
Yıldız Technical University
https://orcid.org/0009-0008-1254-2399
gonchaazada@gmail.com
Nurlan Amrahov
Baku State University
https://orcid.org/0000-0002-6916-7672
nurlanamrahov@bsu.edu.az
The Impact of Quercetin Glycosides on ACE2, AT1R, and AT2R:
The Molecular Docking and in Silico Analysis
Abstract
The renin-angiotensin-aldosterone system (RAAS) plays a critical role in cardiovascular homeostasis, and its dysregulation is associated with hypertension and thrombotic disorders. In this study, we performed a comparative molecular docking analysis of four quercetin glycoside derivatives against three key RAAS-related targets: angiotensin-converting enzyme 2 (ACE2), angiotensin II type 1 receptor (AT1R), and angiotensin II type 2 receptor (AT2R). The aim is to identify ligands that inhibit AT1R to lower blood pressure, without antagonizing ACE2 and AT2R functions which are protective against thrombosis and endothelial dysfunction. The results showed quercetin 5-glucoside and 7-glucoside are promising dual-function ligands with selective AT1R inhibition and peripheral, non-blocking interaction with ACE2 and AT2R.
Keywords: RAAS, ACE2, AT1R, AT2R, quercetin glycosides, molecular docking